You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯環藥業(600513.SH):擬3億元新建廠房、生產線

格隆匯7月15日丨聯環藥業(600513.SH)公佈,公司及公司全資子公司揚州製藥有限公司(簡稱“揚州製藥”)擬規劃共出資30,000.00萬元人民幣於公司西南角土地建設三棟廠房,分別爲出口製劑廠房、抗腫瘤合成廠房和抗腫瘤製劑廠房,其中聯環藥業擬以自籌資金合計15,000.00萬元人民幣出資建設出口製劑藥廠房、抗腫瘤合成廠房和抗腫瘤製劑廠房及生產線,包含抗腫瘤細胞毒合成生產線(包括精烘包)和抗腫瘤非細胞毒合成生產線(包括精烘包);抗腫瘤製劑廠房包含抗腫瘤細胞毒類口服藥物生產線、抗腫瘤非細胞毒類口服藥物生產線,揚州製藥擬以自有資金合計15,000.00萬元人民幣出資建設出口製劑藥生產線及配套立體庫。廠房內包含激素類小容量注射劑及凍幹生產線、激素類固體制劑生產線、普通小容量注射劑及凍幹生產線、普通固體制劑生產線及配套的立體庫。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account